Introduction
Ribosome-inactivating proteins (RIPs) are a group of cytotoxins, which possess a unique rRNA N-glycosidic activity by hydrolyzing a single N-glycoside bond between adenine and ribose at A4324 in the 28S rRNA of rat liver ribosomes. This damages the ribosomes irreversibly with the consequent arrest of protein synthesis Endo et al., 1987; Stirpe et al., 1988) . They are abundant and widely distributed in higher plant species. RIPs can be classi®ed into type I and type II. Type I RIPs are basic, single-chain proteins with molecular weights of~30 kDa. They are potent inhibitors of protein synthesis in the cell-free system. Unlike type II RIPs, type I RIPs are single-chain proteins without B chain. As a result, they are relatively non-toxic to the intactness of the whole cell. Type II RIPs consist of a catalytically active A chain linked to a carbohydrate-binding B chain by a disul®de linkage. The A chain is homologous with type I RIP and is responsible for the toxicity of the molecule. The B chain possesses lectin properties which facilitate entry of the A chain into the cytoplasm of the cell (Li et al., 1999) .
Trichosanthin (TCS) is a type I RIP isolated from the root tuber of Trichosanthes kirilowii Maximowicz (Jimenez and Vazquez, 1985; Stirpe and Barbieri, 1986; Zhang and Wang, 1986; Yeung et al., 1988) . It has 247 amino acids and can inactivate eukaryotic ribosomes via its N-glycosidase activity. It possesses a large N-terminal domain, residues 1±202 and a small C-terminal domain, residues 203±247 (Stirpe and Barbieri, 1986) . The active pocket responsible for N-glycosidase activity is located in the cleft between the two domains (Gao et al., 1994) . TCS has been used extensively for inducing mid-term abortion and treating ectopic pregnancies, hydatidiform and trophoblastic moles in China (Huang, 1987; Lu and Jin, 1990) . In recent years, TCS had also been found to possess various pharmacological properties including immunomodulatory, anti-tumor and anti-HIV activities . Clinical trials have been performed, with resulting increases of CD4 + and CD8 + T cells in patients (McGrath et al., 1989; Byers et al., 1990) .
Although TCS is effective in killing tumor cells in vivo and in vitro, its side effects on patients have not been systematically evaluated. In the long run, it would be useful if the antigenicity of TCS could be reduced and its half-time in vivo increased. It is possible to reduce the antigenicity of TCS by site-speci®c coupling of PEG modi®cation (PEGylation) (He et al., 1999) or by deleting the C-terminal residues (Chan et al., 2000) . Reducing molecular weight could also reduce its antigenicity (Chan et al., 2000) . TCS-C7, generated by deleting the last seven C-terminal amino acid residues, has a 2.7-fold decrease in antigenicity compared with TCS. Although the in vitro ribosome-inactivation activity and in vivo cytotoxicity towards K562 cells have decreased by 10-fold from the wild type (WT), it is still a potent RIP that is effective in the nanomolar range (Chan et al., 2000) . On the other hand, it is interesting to note that mutants with more than seven residues deleted from the Cterminus are expressed as inclusion body, and fail to refold under the in¯uence of urea or guanidine hydrochloride (GnHCl) (Chan et al., 2000) .
In order to explore the role of the C-terminal residues, the crystal structure of TCS-C7 has been determined and compared with the structure of the wild-type TCS (WT-TCS). Further protein engineering based on the structure was performed, with the result that the mutation of Trp192 greatly decreased the The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability ribosome-inactivating activity and stability of TCS. The crystal structures of TCS-W192F and TCS-C7-W192F were also determined.
Materials and methods

Construction of TCS-C7 expression vectors and protein puri®cation
The expression vectors were constructed by Chan et al. (Chan et al., 2000) . Protein expression and puri®cation were performed as described previously (Wong et al., 1994) . Mutation and expression of TCS-W192F and TCS-C7-W192F A site-directed mutant at position 192 of TCS and the deletion mutant TCS-C7 were generated by PCR mutagenesis using Pfu DNA polymerase (Strategene) on pET8C carrying the WT-TCS and TCS-C7 sequences, respectively. The PCR product was cleaved by NcoI and BamHI and cloned to pET8C for expression. The mutations were con®rmed by DNA sequencing. Single colony was innoculated to 2 l of M9ZB medium containing 50 mg/ml ampicillin and 25 mg/ml chloramphenicol at 37°C until OD 600 reached 0.6±0.8 and the protein was induced by 0.4 mM IPTG at 25°C for 3±4 h. The protein was puri®ed with an 8 Q 2.5 cm CM-Sepharose CL6B column (Amersham Pharmacia Biotech) followed by a HiTrap SPSepharose fast¯ow column (Amersham Bioscience) using 20 mM phosphate buffer with a 0±1 M NaCl gradient. Crystallization Crystals of TCS-C7 were grown by the hanging-drop vapor diffusion method with a protein concentration of~20 mg/ ml. The reservoir contained 100 mM CaCodylate, pH 6.5, 200 mM CaOAc 2 and 15% PEG8000 (Li et al., 2002) . The crystallization condition of TCS-C7-W192F was similar to TCS-C7. Crystals of TCS-W192F were grown according to the crystallization condition of WT-TCS (Gao et al., 1994) . The protein concentration was~40 mg/ml, and the reservoir contained 100 mM NaOAc±HOAc, pH 4.5, 100 mM CaCl 2 and 20% KCl.
Diffraction and data collection
Diffraction data of the crystals were collected at 100 K on an in-house Mar345 image plate with a Rigaku rotating Cu Ka anode X-ray generator at 48 kV and 98 mA (l = 1.5418 A Ê ). The crystals of TCS-C7 and TCS-C7-W192F belong to space group P2 1 with four protein molecules in the asymmetric unit, while the crystals of TCS-W192F belong to space group P2 1 2 1 2 1 with one protein molecule in the asymmetric unit. Indexing and integration of all images were performed in DENZO and scaling of the intensity data was performed in SCALEPACK; both are from the HKL program package (Otwinowski and Minor, 1997) . The crystal parameters and data collection statistics are listed in Table I .
Structure determination and re®nement TCS-C7. Molecular replacement. The TCS-C7 structure was solved by the molecular replacement method. The processing was carried out with CNS (Brunger et al., 1998) using the TCS-NADPH complex (PDB code 1TCS) molecule as a search model. The NADPH molecule and all water molecules were discarded and the temperature factors of all remaining atoms were ®xed at 20.0 A Ê 2 . The rotation and translation function calculation was carried out using the data in the resolution range 15±3.5 A Ê . According to the self-rotation function, it Numbers in parentheses correspond to the highest resolution shell (2.07±2.0 A Ê ). a R merge = S hkl |I i ± I m | / S hkl I m, where I i and I m are the observed intensity and the mean intensity of related re¯ections, respectively. b Ten percent of the total re¯ections were used for R free calculation. c The quality of the structures of one molecule in the asymmetric unit was assessed using PROCHECK and statistics are given for the monomer.
appeared there were four molecules in an asymmetric unit. Finally, four molecules were located in an asymmetric unit just as predicted and the molecular packing in the unit cell is plausible.
Crystallographic re®nement. The model was rebuilt with O (Jones et al., 1991) and re®ned with CNS. No data truncation was applied in the re®nement. Ten percent of the data were set aside in order to calculate the free R-factor. After a rigid body The structural basis of Trp192 and the C-terminal region re®nement, the R-value dropped to 0.373 and R free was 0.403 for the data in the resolution range 40±3 A Ê . The last seven residues were deleted from the protein structure and this model was then re®ned by simulated annealing using data in the resolution range 40±2.5 A Ê . A starting temperature of 5000 K was gradually decreased to 300 K in steps of 50 K. At this stage, the R-factor and R free were 0.262 and 0.317, respectively. Using the 40±2.0 A Ê data, 2|F o | ± |F c | and |F o | ± |F c | electron density maps were calculated and examined in O. The re®nement was completed by alternating between manual building and minimization using data in the resolution range 40±2.0 A Ê . Group B-factor re®nement was then used to re®ne the temperature factors in the model. In each re®nement step, initial anisotropic overall B-factor correction with a lower resolution limit of 6 A Ê and bulk-solvent correction were applied to the data. 1120 water molecules were located automatically with CNS. The water molecules with thermal factors higher than 50 A Ê 2 were removed. TCS-W192F and TCS-C7-W192F. Since the crystal of TCS-W192F is isomorphous with WT-TCS and the crystal of TCS-C7-W192F is isomorphous with TCS-C7, the 2|F o | ± |F c | and |F o | ± |F c | difference electron density maps were calculated by the difference Fourier method with the collected diffraction data as F o and the structure of the isomorphous model as F c . Most of the residues ®t well in the 2|F o | ± |F c | map. When W192 was omitted from the 2|F o | ± |F c | and |F o | ± |F c | maps, the side chain is like a phenyl ring. This suggested that W192 has been mutated to Phe. As a result, W192 was changed to Phe for further re®nement using the program O. Re®nement of the two structures was also performed using CNS. In each case, the re®nement was completed by alternating between manual building and minimization using data in the resolution range 40±2.0 A Ê .
Ribosome-inactivating activity assay
The ribosome-inactivating activity assay was determined by an in vitro translation system using rabbit reticulocyte lysate (Promega), as previously described (Chan et al., 2000) . GnHCl denaturation CD spectra in the peptide region (190±260 nm) were measured with a Jasco J-810 spectropolarimeter at 37°C. Protein samples (10 mM) were treated with GnHCl concentrations between 0.0 and 7.0 M in 20 mM phosphate buffer, pH 6.7. The protein samples were equilibrated with GnHCl solution for 30 min. Each protein was scanned three times from 190 to 260 nm and the spectra were averaged, subtracted from buffer blank spectrum and expressed as residual molar ellipticity (RME) with adjustment of the number of amino acid residues of each variant proteins. The RME at 222 nm, the prominent band contributed by the secondary structure, was plotted against different concentrations of GnHCl.
Results
Quality of the crystal structures
The re®nement statistics are listed in Table I . The atomic positions of every residue were veri®ed by the omit electron density map. After re®nement, the R-factor and r.m.s.d. of bond length and bond angle of these structures are rational. The program PROCHECK (Laskowski et al., 1993) was used to check the stereochemistry of the structures: the Ramachandran plot shows that 91.0, 92.5 and 89.9% of the non-glycine and non-proline residues fall in the core region in TCS-C7, TCS-W192F, TCS-C7-W192F structures, respectively; the remainder are in the allowed region and no residues were found in the disallowed region.
Hydrogen bonds bridging N-and C-terminal domains are lost in TCS-C7
The overall structure of TCS-C7 is displayed as a ribbon diagram in Figure 1A . The Ca r.m.s.d.s between TCS-C7 and WT-TCS are small, suggesting there are no signi®cant structural differences between TCS-C7 and WT-TCS, except that TCS-C7 has a shortened C-terminus. The C-terminal tail of TCS, sandwiched between helix 7 and the b-hairpin formed by strands 2 and 3, serves to connect the N-terminal domains (1±202) and the C-terminal domains (203±247) of TCS together. A number of hydrogen bonds link the C-terminal tail to the N-terminal domain. They can be classi®ed into two groups: (i) hydrogen bonds that link to the bhairpin; and (ii) hydrogen bonds that link to helix 7 (Table II) ( Figure 1B) . While in TCS-C7, all of these hydrogen bonds, except for those between Leu239 O ¼ Trp192 NE1 and Leu240 N ¼ Pro35 O, were removed by deleting the last seven residues. In TCS-C7, one of the C-terminal oxygen atoms occupies the void left by Leu241 N and forms a hydrogen bond to Ser196 OG, replacing the hydrogen bond Ser196 OG ¼ Leu241 N in WT-TCS ( Figure 1C) .
The solvent accessible surface areas of Trp192 calculated for TCS-C7 and WT-TCS are 23.08 and 11.26 A Ê 2 , respectively. This result agrees with our previous observation that thē uorescence spectrum of C7 was red-shifted, suggesting a high solvent exposure for the¯uorophore Trp192.
Structures of the W192F mutants
Trp192 is an invariant residue within the RIP family. To observe the effect of removing the hydrogen bond in Trp192, it was replaced by Phe in WT-TCS and TCS-C7. In the structures of TCS-W192F and TCS-C7-W192F, Phe192 ®ts their electron density maps well. In order to reveal the effects of the W192F mutation, the TCS, TCS-C7, TCS-W192F and TCS-C7-W192F structures were superimposed. The r.m.s.d.s among them were all in the range 0.2±0.6 A Ê . No major structural changes were observed upon mutation of W192F.
Ribosome-inactivating activities of TCS mutants
The ribosome-inactivating activities of TCS mutants were WT-TCS (IC 50 = 0.17 nM), TCS-C7 (IC 50 = 1.8 nM), TCS-W192F (IC 50 = 1.3 nM), TCS-C7-W192F (IC 50 = 10 nM). The activities of both TCS-C7 and TCS-W192F decreased~10-and ~7-fold, respectively. The effect of deletion of the C-terminal residues and W192F appeared to be cumulativeÐthe TCS-C7-W192F mutant has a~60-fold reduction in activity.
Destabilized C7 mutants unfold via an intermediate state
The unfolding of WT-TCS follows an apparent two-state model, in which only the folded or the completely unfolded states exist. However, for TCS-C7, a plateau of the unfolding curve was observed at~2±3 M GnHCl, indicating the presence of a partially structured intermediate (Figure 2 ). Judging by the RME at 222 nm, the intermediate state retained~75% helical content. Intermediate states were also observed for TCS-C7-W192F and, to a lesser extent, TCS-W192F. Although quanti®cation of thermodynamic parameters is not possible for non-two-state systems, the relative stability of TCS and mutants was found to be WT > W192F > C7 > C7-W192F. Both the deletion of the C-terminal residues and the mutation of W192F destabilized TCS.
Discussion
Role of Trp192
Mutagenesis of Trp192 to Phe has resulted in variants with a signi®cant reduction in conformational stability and a decrease in ribosome-inactivating activity. The NE1 of Trp192 forms a hydrogen bond with the main chain O atom of the residue Leu239. Moreover, the indole ring of Trp192 forms hydrophobic interactions with the side chains of Arg163 and Leu241. The large reduction in stability is likely due to the removal of these interactions as a result of the W192F mutation. Trp192 is one of the few residues around the active pocket that are invariant throughout the RIP family, including the ricin A chain (Katzin et al., 1991) . Mutation of the corresponding Trp to Phe in ricin A also results in a less active variant (Bradley and McGuire, 1990) . Trp192 in TCS forms the bottom of the hydrophobic cavity and is involved in the de®nition of the binding site, presumably to stabilize the ligand inside the cavity and to protect it from the solvent. Our work has con®rmed that although there are no large structural changes after mutating this conserved Trp, this amino acid residue does in fact play an important role in catalysis and in maintaining the protein stability in this class of proteins.
Role of the C-terminal tail
In our previous study, we demonstrated that the antigenicity of TCS can be reduced without a large compromise of activity by coupling a C-terminal residue, Gln219, to polyethylene glycol (He et al., 1999) or by the deletion of the C-terminal residues (Chan et al., 2000) . These approaches to reduce the antigenicity of TCS were successful since the C-terminal domain is far away from the active site. The crystal structure of TCS-C7 determined in the present study has con®rmed that deletion of the C-terminal residue does not affect the active site structure of TCS.
The major role of the C-terminal tail appears to be to stabilize the structure of TCS. Deletion of the last seven residues of TCS results in a large reduction,~5 kcal/mol, in free energy of unfolding (Chan et al., 2000) , and the accumulation of a partially structured intermediate at 2±3 M GnHCl. Since the C-terminal tail forms a number of interactions bridging the C-and the N-terminal domains (in particular, helix 7 and the hairpin of strands 2 and 3), it is reasonable to hypothesize that removal of the tail destabilizes the C-terminal domain and H7. Circular dichroism data suggest that the intermediate retains~75% helical structure, which can be accounted for if helix 7 and the C-terminal domain are unfolded. It is likely that the partially structured intermediate retains a structured N-terminal domain that is further unfolded only when the concentration of GnHCl reaches~4 M.
The antigenicity, measured by binding the anti-TCS mAB (IC 50 ) of TCS-C7, was 0.3 mM compared with 0.1 mM for the WT. The IC 50 for ribosome-inactivating activities of C7 and WT-TCS were 1.8 and 0.17 nM, respectively. Although the activity of TCS-C7 is reduced~10-fold to 1.8 nM, it should still be a very strong RIP at micromolar concentrations where antigenicity matters. Also, while TCS-C7 may not be effective as a drug at this stage, our work has shown that the C-terminal The structural basis of Trp192 and the C-terminal region region has a role in antigenicity and this will help us to modify it further. Role of the hydrogen bonds related to Leu240 Our experiments to systematically delete the C-terminal residues have shown that TCS-C8 and TCS-C9 (with the last eight and nine residues deleted, respectively) were expressed solely as inclusion bodies and they cannot be refolded to the native conformation. Deleting residues 240 and 239 results in a complete loss of the hydrogen bonds between the tail of the Cterminal domain and N-terminal domain, thus the entire molecule cannot be refolded to its native conformation. This shows that the tail of the C-terminus, especially the three remaining hydrogen bonds in TCS-C7, plays an important role in maintaining the link between the N-and C-terminal domains and is required for the folding of TCS.
Compared with TCS-C7, the hydrogen bond between Leu239 and Trp192 NE1 disappears in TCS-C7-W192F, which can be refolded to native conformation successfully. On the other hand, TCS-C8 cannot be refolded to native conformation. There is only one amino acid difference between TCS-C8 and TCS-C7, Leu240, which leads to the absence of two hydrogen bonds related to Leu240. These results suggest that the hydrogen bonds formed by residue Leu240 are the key in maintaining the link between N-and C-terminal domains in TCS-C7.
The TCS-C7 coordinates have been deposited in the Protein Data Bank with accession code 1J4G.
